Atrogi AB
PrivateLast Round
Series B
Mar 14, 2024
Total Funding Raised
$1.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Atrogi AB operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Grant round in June 2020.
Atrogi AB is a biotechnology company that develops first-in-class, insulin-independent small molecule treatments for type 2 diabetes, obesity, and muscle-wasting disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atrogi AB Comparables
Compare Atrogi AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rivus Pharmaceuticals | 81% | |
| Biolexis Therapeutics, Inc. | 80% | |
| Eolo Pharma | 77% |
For institutional investors. Book with your work email.
Atrogi AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 14, 2024 | ||||
| Grant | Jun 25, 2020 | ||||
| VC Round | Jun 9, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Atrogi AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | VC Round |
| Flerie AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 129% MoM, reaching 1.6K.
- Jul 27, 2026
Monthly visitors increased 153% MoM.
For institutional investors. Book with your work email.
Atrogi AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atrogi AB's valuation, stock price, and market status.
Is Atrogi AB a public or private company?
Atrogi AB is a private company.
What is the current stock price of Atrogi AB?
Atrogi AB is a private company, so its shares have no public market price. Caplight tracks Atrogi AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atrogi AB worth (valuation)?
Valuation information for Atrogi AB is not publicly available.
Can I buy Atrogi AB stock?
Atrogi AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atrogi AB's last funding round?
Atrogi AB's most recent funding round was Series B on March 14, 2024.
Who are the main investors in Atrogi AB?
Key investors in Atrogi AB include Korea Investment Partners, Flerie AB.
Will Atrogi AB IPO soon?
No public IPO plans have been announced for Atrogi AB.
How can I track Atrogi AB secondary market activity?
Caplight tracks bids, offers, and trades in Atrogi AB's shares on secondary markets.